Higher Tissue Concentrations of Vancomycin Achieved with Low Dose Intraosseous Injection versus Intravenous Despite Limited Tourniquet Duration in Primary TKA: A Randomized Trial.

[1]  S. Incavo,et al.  2021 Chitranjan S. Ranawat Award: Intraosseous vancomycin reduces periprosthetic joint infection in primary total knee arthroplasty at 90-day follow-up. , 2021, The bone & joint journal.

[2]  J. Bosco,et al.  Incomplete Administration of Intravenous Vancomycin Prophylaxis is Common and Associated With Increased Infectious Complications After Primary Total Hip and Knee Arthroplasty. , 2021, The Journal of arthroplasty.

[3]  S. Young,et al.  Intraosseous Regional Administration of Vancomycin in Primary Total Knee Arthroplasty Does Not Increase the Risk of Vancomycin-Associated Complications. , 2020, The Journal of arthroplasty.

[4]  S. Odum,et al.  Why Do Revision Total Knee Arthroplasties Fail? A Single-Center Review of 1632 Revision Total Knees Comparing Historic and Modern Cohorts. , 2020, The Journal of arthroplasty.

[5]  S. Incavo,et al.  Clinical outcome evaluation of intraosseous vancomycin in total knee arthroplasty , 2020, Arthroplasty today.

[6]  Vancomycin , 2019, Reactions Weekly.

[7]  S. Hu,et al.  Does Tourniquet Use in TKA Increase Postoperative Pain? A Systematic Review and Meta-analysis , 2018, Clinical orthopaedics and related research.

[8]  S. Kohl,et al.  Periprosthetic Infection: Major Cause of Early Failure of Primary and Revision Total Knee Arthroplasty , 2018, The Journal of Knee Surgery.

[9]  S. Young,et al.  The AAHKS Clinical Research Award: Intraosseous Regional Prophylaxis Provides Higher Tissue Concentrations in High BMI Patients in Total Knee Arthroplasty: A Randomized Trial. , 2018, The Journal of arthroplasty.

[10]  E. Leary,et al.  Dual-Agent Antibiotic Prophylaxis Using a Single Preoperative Vancomycin Dose Effectively Reduces Prosthetic Joint Infection Rates With Minimal Renal Toxicity Risk. , 2018, The Journal of arthroplasty.

[11]  S. Young,et al.  The John N. Insall Award: Higher Tissue Concentrations of Vancomycin Achieved With Intraosseous Regional Prophylaxis in Revision TKA A Randomized Controlled Trial , 2018, Clinical orthopaedics and related research.

[12]  S. Young,et al.  Periprosthetic Joint Infection Is the Main Cause of Failure for Modern Knee Arthroplasty: An Analysis of 11,134 Knees , 2017, Clinical orthopaedics and related research.

[13]  A. Hanssen,et al.  Contemporary failure aetiologies of the primary, posterior‐stabilised total knee arthroplasty , 2017, The bone & joint journal.

[14]  J. Parvizi,et al.  Vancomycin Prophylaxis for Total Joint Arthroplasty: Incorrectly Dosed and Has a Higher Rate of Periprosthetic Infection Than Cefazolin , 2017, Clinical orthopaedics and related research.

[15]  Jingcheng Wang,et al.  Timing of tourniquet release in total knee arthroplasty , 2017, Medicine.

[16]  D. Dennis,et al.  Does Tourniquet Use in TKA Affect Recovery of Lower Extremity Strength and Function? A Randomized Trial , 2016, Clinical orthopaedics and related research.

[17]  A. Jawhar,et al.  Tourniquet-induced ischaemia during total knee arthroplasty results in higher proteolytic activities within vastus medialis cells: a randomized clinical trial , 2016, Knee Surgery, Sports Traumatology, Arthroscopy.

[18]  S. Young,et al.  Regional Intraosseous Administration of Prophylactic Antibiotics is More Effective Than Systemic Administration in a Mouse Model of TKA , 2015, Clinical orthopaedics and related research.

[19]  Nishikant Kumar,et al.  Evaluation of pain in bilateral total knee replacement with and without tourniquet; a prospective randomized control trial. , 2015, Journal of clinical orthopaedics and trauma.

[20]  Guang-Feng Zhao,et al.  Use of a tourniquet in total knee arthroplasty: a systematic review and meta-analysis of randomized controlled trials , 2015, Journal of orthopaedic science : official journal of the Japanese Orthopaedic Association.

[21]  Mei Zhang.  Determination of Vancomycin in Human Plasma, Bone and Fat by Liquid Chromatography/Tandem Mass Spectrometry , 2014 .

[22]  T. Sculco,et al.  Periprosthetic joint infections treated with two-stage revision over 14 years: an evolving microbiology profile. , 2014, The Journal of arthroplasty.

[23]  James I Huddleston,et al.  Current Modes of Failure in TKA: Infection, Instability, and Stiffness Predominate , 2014, Clinical orthopaedics and related research.

[24]  P. Pavlou,et al.  The Mark Coventry Award: Higher Tissue Concentrations of Vancomycin With Low-dose Intraosseous Regional Versus Systemic Prophylaxis in TKA , 2014, Clinical orthopaedics and related research.

[25]  T. Vail,et al.  Targeted Use of Vancomycin as Perioperative Prophylaxis Reduces Periprosthetic Joint Infection in Revision TKA , 2014, Clinical orthopaedics and related research.

[26]  S. Young,et al.  Higher Cefazolin Concentrations with Intraosseous Regional Prophylaxis in TKA , 2013, Clinical orthopaedics and related research.

[27]  A. Bull,et al.  Impact of Vancomycin Surgical Antibiotic Prophylaxis on the Development of Methicillin-Sensitive Staphylococcus aureus Surgical Site Infections: Report From Australian Surveillance Data (VICNISS) , 2012, Annals of surgery.

[28]  Eric B. Smith,et al.  Is it time to include vancomycin for routine perioperative antibiotic prophylaxis in total joint arthroplasty patients? , 2012, The Journal of arthroplasty.

[29]  J. Solomkin,et al.  Vancomycin for surgical prophylaxis? , 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[30]  D. Pittet,et al.  Meticillin resistance in orthopaedic coagulase-negative staphylococcal infections. , 2011, The Journal of hospital infection.

[31]  Sakae Tanaka,et al.  Are Bone and Serum Cefazolin Concentrations Adequate for Antimicrobial Prophylaxis? , 2011, Clinical orthopaedics and related research.

[32]  A. Ross,et al.  Intraosseous Infusions: A Review for the Anesthesiologist with a Focus on Pediatric Use , 2010, Anesthesia and analgesia.

[33]  M. Porter,et al.  The microbiology of the infected knee arthroplasty , 2010, International Orthopaedics.

[34]  I. Shavit,et al.  Comparison of two mechanical intraosseous infusion devices: a pilot, randomized crossover trial. , 2009, Resuscitation.

[35]  J. Burke,et al.  Timing of Antimicrobial Prophylaxis and the Risk of Surgical Site Infections: Results From the Trial to Reduce Antimicrobial Prophylaxis Errors , 2009, Annals of surgery.

[36]  A. Atanda,et al.  Compartment syndrome of the leg after intraosseous infusion: guidelines for prevention, early detection, and treatment. , 2008, American journal of orthopedics.

[37]  D. Paterson,et al.  Antibiotic resistance—What’s dosing got to do with it? , 2008, Critical care medicine.

[38]  C. P. Mahoney,et al.  Intra-Osseous Access (EZ-IO®) for Resuscitation: UK Military Combat Experience , 2007, Journal of the Royal Army Medical Corps.

[39]  I. Gyssens,et al.  Antibiotic prophylaxis and the risk of surgical site infections following total hip arthroplasty: timely administration is the most important factor. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[40]  D. Deleu,et al.  Red man syndrome , 2002, Critical care.

[41]  M. Roffman,et al.  Intraosseous regional anesthesia as an alternative to intravenous regional anesthesia. , 1995, The Journal of trauma.

[42]  B. Katona,et al.  Association of Vancomycin Serum Concentrations With Outcomes in Patients With Gram‐Positive Bacteremia , 1995, Pharmacotherapy.

[43]  C. Price,et al.  Compartment syndrome of the lower extremity after intraosseous infusion of fluid. A report of two cases. , 1993, The Journal of bone and joint surgery. American volume.

[44]  David C. Classen,et al.  The timing of prophylactic administration of antibiotics and the risk of surgical-wound infection. , 1992, The New England journal of medicine.

[45]  R. Polk,et al.  Vancomycin-induced histamine release and "red man syndrome": comparison of 1- and 2-hour infusions , 1990, Antimicrobial Agents and Chemotherapy.

[46]  D. T. Rock,et al.  Vancomycin and the red-man syndrome: pharmacodynamics of histamine release. , 1988, The Journal of infectious diseases.

[47]  F. Tudvad,et al.  Bone marrow infusion in childhood , 1947 .